Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

ClinicalTrials.gov ID: NCT03817502

Public ClinicalTrials.gov record NCT03817502. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Study identification

NCT ID
NCT03817502
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gedeon Richter Plc.
Industry
Enrollment
330 participants

Conditions and interventions

Conditions

Interventions

  • Cariprazine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2019
Primary completion
Dec 14, 2026
Completion
Dec 14, 2026
Last update posted
Oct 7, 2025

2019 – 2026

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
ProScience Research Group Culver City California 90230 Completed
Atlanta Center for Medical Research Atlanta Georgia 30331 Completed
Atlanta Behavioral Research, LLC Atlanta Georgia 30338 Withdrawn
Bloomfield Hills MI Bloomfield Hills Michigan 48302 Withdrawn
Precise Research Centers Flowood Mississippi 39232 Withdrawn
UB Department of Psychiatry Buffalo New York 142515 Withdrawn
Manhattan Behavioral Medicine PLLC New York New York 10036 Withdrawn
University of Cincinnati Cincinnati Ohio 45219 Completed
Family Psychiatry of The Woodlands The Woodlands Texas 77381 Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03817502, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03817502 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →